Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients with Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

  1. Canales, M.A.
  2. Buchholz, T.A.
  3. Bortolini, J.A.P.
  4. Fogliatto, L.M.
  5. Ishikawa, T.
  6. Izutsu, K.
  7. Salar, A.
  8. Sharman, J.P.
  9. Klingbiel, D.
  10. Pokala, S.
  11. Vorozheikina, E.
  12. Trask, P.
  13. Parreira, J.
  14. Hübel, K.
Revista:
HemaSphere

ISSN: 2572-9241

Any de publicació: 2023

Volum: 7

Número: 4

Pàgines: E860

Tipus: Carta

DOI: 10.1097/HS9.0000000000000860 GOOGLE SCHOLAR lock_openAccés obert editor